Neuronetics Inc reports results for the quarter ended in December - Earnings Summary

Neuronetics

05/03/2024 23:51

* Neuronetics Inc  STIM.OQ  reported a quarterly adjusted
loss
of 19 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -30 cents.  The mean expectation of
four analysts for the quarter was for a loss of 26 cents per
share. Wall Street expected results to range from -27 cents
to -25 cents per share.
    * Revenue rose 11.6% to $20.31 million from a year ago;
analysts
expected $19.85 million. 
    * Neuronetics Inc's reported EPS for the quarter was a loss
of 19
cents​.
    * The company reported a quarterly loss of $5.38 million.
    * Neuronetics Inc shares had fallen by 3.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Neuronetics Inc
is $7.00 
This summary was machine generated from LSEG data March 5 at
11:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.26          -0.19          Beat
 Sep. 30 2023      -0.31          -0.33          Missed
 Jun. 30 2023      -0.35          -0.17          Beat
 Mar. 31 2023      -0.39          -0.38          Beat